These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 12740016)
41. Effects of thyrotropin-releasing hormone in vitro on thyrotropin and prolactin release from the turtle pituitary. Preece H; Licht P Gen Comp Endocrinol; 1987 Aug; 67(2):247-55. PubMed ID: 3114044 [TBL] [Abstract][Full Text] [Related]
42. Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells. Strowski MZ; Dashkevicz MP; Parmar RM; Wilkinson H; Kohler M; Schaeffer JM; Blake AD Neuroendocrinology; 2002 Jun; 75(6):339-46. PubMed ID: 12065886 [TBL] [Abstract][Full Text] [Related]
43. Mechanisms of action of somatostatin on human TSH-secreting adenoma cells. Takano K; Ajima M; Teramoto A; Hata K; Yamashita N Am J Physiol; 1995 Apr; 268(4 Pt 1):E558-64. PubMed ID: 7733252 [TBL] [Abstract][Full Text] [Related]
44. Benzodiazepine antagonism of thyrotrophin-releasing hormone receptors: biphasic actions on growth hormone secretion in domestic fowl. Harvey S J Endocrinol; 1993 Apr; 137(1):35-42. PubMed ID: 8388014 [TBL] [Abstract][Full Text] [Related]
45. Interaction of human pancreatic growth hormone-releasing factor, thyrotropin-releasing hormone, and somatostatin on growth hormone release in chickens. Taylor JE; Ball CA; Leung FC Proc Soc Exp Biol Med; 1986 Dec; 183(3):363-7. PubMed ID: 2879290 [TBL] [Abstract][Full Text] [Related]
46. Ontogenetic development of the inhibition of growth hormone release by somatostatin in the rat: in-vivo and in-vitro (perifusion) study. Rieutort M J Endocrinol; 1981 Jun; 89(3):355-63. PubMed ID: 6114124 [TBL] [Abstract][Full Text] [Related]
47. [Neurohormones coming from the normal and tumoral human anterior pituitary. Secretion and regulation in vitro]. Peillon F; Le Dafniet M; Garnier P; Feinstein MC; Donnadieu M; Barret A; Gautron JP; Brandi AM; Benlot C; Lagoguey A Pathol Biol (Paris); 1989 Sep; 37(7):840-5. PubMed ID: 2576565 [TBL] [Abstract][Full Text] [Related]
48. Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats. Schmid HA; Silva AP J Endocrinol Invest; 2005; 28(11 Suppl International):28-35. PubMed ID: 16625842 [TBL] [Abstract][Full Text] [Related]
49. In-vitro control of growth hormone secretion by synthetic releasing factors in young and adult ducks (Anas platyrhynchos). Foltzer-Jourdainne C; Harvey S; Mialhe P J Endocrinol; 1988 Dec; 119(3):421-9. PubMed ID: 2906084 [TBL] [Abstract][Full Text] [Related]
50. Regulation of growth hormone expression by thyrotropin-releasing hormone through the pituitary-specific transcription factor Pit-1 in chicken pituitary. Van As P; Careghi C; Bruggeman V; Onagbesan OM; Van der Geyten S; Darras VM; Decuypere E Acta Vet Hung; 2004; 52(4):389-402. PubMed ID: 15595273 [TBL] [Abstract][Full Text] [Related]
51. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects. Park S; Kamegai J; Kineman RD Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709 [TBL] [Abstract][Full Text] [Related]
52. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors. Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020 [TBL] [Abstract][Full Text] [Related]
55. Effects of synthetic mammalian thyrotrophin releasing hormone, somatostatin and dopamine on the secretion of prolactin and growth hormone from amphibian and reptilian pituitary glands incubated in vitro. Hall TR; Chadwick A J Endocrinol; 1984 Aug; 102(2):175-80. PubMed ID: 6146654 [TBL] [Abstract][Full Text] [Related]
56. Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Strowski MZ; Parmar RM; Blake AD; Schaeffer JM Endocrinology; 2000 Jan; 141(1):111-7. PubMed ID: 10614629 [TBL] [Abstract][Full Text] [Related]
57. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264 [TBL] [Abstract][Full Text] [Related]
58. Effects of growth hormone-releasing factor and somatostatin on growth hormone secretion in hypophysial stalk-transected beef calves. Plouzek CA; Molina JR; Hard DL; Vale WW; Rivier J; Trenkle A; Anderson LL Proc Soc Exp Biol Med; 1988 Nov; 189(2):158-67. PubMed ID: 2904152 [TBL] [Abstract][Full Text] [Related]
59. Thyrotropin-Releasing Hormone (TRH) and Somatostatin (SST), but not Growth Hormone-Releasing Hormone (GHRH) nor Ghrelin (GHRL), Regulate Expression and Release of Immune Growth Hormone (GH) from Chicken Bursal B-Lymphocyte Cultures. Pech-Pool S; Berumen LC; Martínez-Moreno CG; García-Alcocer G; Carranza M; Luna M; Arámburo C Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093298 [TBL] [Abstract][Full Text] [Related]
60. Involvement of somatostatin receptor subtypes in membrane ion channel modification by somatostatin in pituitary somatotropes. Yang SK; Chen C Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1221-7. PubMed ID: 17892506 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]